MARIZYME
Marizyme is a development-stage company dedicated to the commercialization of therapies that address the urgent need for higher mortality and costs in the acute care space. The company's first product candidates are derived from a broad intellectual property portfolio around a novel system of proteolytic enzymes called ProteomeX (previously referred to as Krillase Technology). Marizyme completed the acquisition of these assets and intends to immediately develop several product candidates that will address unmet medical needs in the acute care setting.
MARIZYME
Social Links:
Industry:
Biotechnology
Founded:
2018-03-01
Address:
Davenport, Florida, United States
Country:
United States
Website Url:
http://www.marizyme.com
Total Employee:
11+
Status:
Active
Contact:
732-723-7395
Total Funding:
5.56 M USD
Technology used in webpage:
Euro Microsoft Exchange Online Office 365 Mail ReCAPTCHA KnowBe4
Similar Organizations
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-12-23 | MyHealth Logic | MyHealth Logic acquired by Marizyme | N/A |
Key Employee Changes
Official Site Inspections
http://www.marizyme.com Semrush global rank: 4.63 M Semrush visits lastest month: 2.15 K
- Host name: 172.67.198.60
- IP address: 172.67.198.60
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Marizyme"
Marizyme, Inc.
Marizyme, Inc. is a multi-technology biomedical company dedicated to the accelerated development and commercialization of medical technologies that improve patient health …See details»
Marizyme, Inc.
Marizyme, Inc. is a multi-technology biomedical company dedicated to the accelerated development and commercialization of medical technologies that improve patient health outcomes. For more information on the opportunity of …See details»
Marizyme Inc. - LinkedIn
Biomedical innovation to improve patient health outcomes. | Marizyme, Inc. is a multi-technology biomedical company dedicated to the accelerated development and commercialization of medical...See details»
Marizyme, Inc. Company Profile | Jupiter, FL - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Marizyme, Inc. of Jupiter, FL. Get the latest business insights from Dun & Bradstreet.See details»
Marizyme - Crunchbase Company Profile & Funding
Marizyme is a development-stage company dedicated to the commercialization of therapies that address the urgent need for higher mortality and costs in the acute care space. The …See details»
Org Chart Marizyme - The Official Board
The organizational chart of Marizyme displays its 12 main executives including David Barthel, George Kovalyov and Harrison Ross Toggle navigation The Official Board SearchSee details»
Marizyme, Inc. (MRZM) Company Profile & Overview - Stock Analysis
Marizyme, Inc., a multi-technology biomedical company, develops and commercializes medical technologies to enhances patients health.See details»
Marizyme, Inc. Appoints Business Executive Julie Kampf …
Marizyme is an integrated life sciences company dedicated to the acquisition, development and commercialization of therapies that minimize mortality and costs in the acute care space.See details»
Marizyme, Inc. - About Us
Marizyme, Inc. is a multi-technology biomedical company dedicated to the accelerated development and commercialization of medical technologies that improve patient health …See details»
Marizyme - Contacts, Employees, Board Members, Advisors
Marizyme has 4 current employee profiles, including Chief Executive Officer David L. Barthel. Marizyme is a development-stage company dedicated to the commercialization of therapies.See details»
Marizyme Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 · Marizyme is a biotechnology company developing treatment of acute ischemic stroke, acute myocardial infactions, deep vein thrombosis, and chronic wounds burns. It offers …See details»
Marizyme, Inc. Strengthens Senior Management Team with Two …
JUPITER, Fla., Feb. 1, 2021 /PRNewswire/ -- Marizyme, Inc. (OTCQB: MRZM), a publicly traded global biotechnology company developing products to reduce the burden of ischemia …See details»
Julie Kampf - Independent Director at Marizyme Inc | The Org
Julie Kampf is a global business executive and thought leader on talent and diversity, with 30 years of experience in the life science and retail/consumer fashion industries and on not-for …See details»
Marizyme, Inc. - About Us
Marizyme, Inc. is a multi-technology biomedical company dedicated to the development and commercialization of medical technologies that improve patient health outcomes. Marizyme's …See details»
Marizyme, Inc. (MRZM) Stock Price & Overview - Stock Analysis
Marizyme, Inc., a multi-technology biomedical company, develops and commercializes medical technologies to enhances patients health.See details»
Marizyme, Inc. Completes Acquisition of Somahlution, Inc. and
Sep 29, 2020 · Marizyme, Inc. is a development-stage company dedicated to the commercialization of innovative therapies that address the urgent unmet needs relating to …See details»
MRZM Stock Price Quote - Morningstar
Nov 21, 2024 · Marizyme Inc is a multi-technology biomedical company dedicated to the accelerated development and commercialization of medical device technologies that improve …See details»
Marizyme, Inc. - Product Pipeline
Innovative technologies and a diverse product pipeline help de-risk product specific execution. Marizyme has focused on large markets including CABG surgery, fat grafting, pet health, and …See details»
Marizyme, Inc. (MRZM) Stock Price, News, Quote & History
Find the latest Marizyme, Inc. (MRZM) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
About Us - Marizyme Inc
Marizyme, Inc. is a multi-technology biomedical company dedicated to the accelerated development and commercialization of medical technologies that improve patient health …See details»